Thursday, September 3, 2015
Amneal Pharmaceuticals has launched Amneal Biosciences, a wholly owned subsidiary. Amneal Biosciences will focus exclusively on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals such as injectables, oncologics and biosimilars to healthcare providers globally.
Becton, Dickinson and Company (BD) has completed its acquisition of Cellular Research, a biotechnology R&D company. Cellular Research has developed advanced tools for massively parallel single cell genetic analysis based on their proprietary molecular indexing technology to enable gene expression profiles from single cells.